<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>The $15bn ‘viral’ AI start-up changing how American doctors treat patients — Live Feed</title><link>https://www.live-feeds.com/feed/the-15bn-viral-ai-start-up-changing-how-american-doctors-treat-patients</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/the-15bn-viral-ai-start-up-changing-how-american-doctors-treat-patients/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>AI Start-Up Valued at $15bn Changes American Medical Care</title><link>https://www.live-feeds.com/feed/the-15bn-viral-ai-start-up-changing-how-american-doctors-treat-patients</link><guid isPermaLink="false">https://www.live-feeds.com/feed/the-15bn-viral-ai-start-up-changing-how-american-doctors-treat-patients#u153727</guid><pubDate>Sun, 25 Oct 2026 10:45:27 +0000</pubDate><description>A viral artificial intelligence start-up valued at $15 billion is reshaping how American doctors treat patients. A first-of-its-kind large-scale study from Harvard Medical School documents an explosion of artificial intelligence adoption by physicians in medicine. Meanwhile, a recent paper in JAMA regarding OpenEvidence leaves open questions about clinical tools. Healthcare systems face ongoing challenges regarding trust, deployment, and practical implementation as clinicians increasingly integrate these systems into daily practice.Why it mattersThe rapid expansion of artificial intelligence i</description></item>
</channel></rss>